Conformis Gains FDA Clearance for Identity Imprint Knee Replacement
Identity Imprint is designed to match patients’ anatomy while offering efficiency, cost savings, intraoperative flexibility and faster delivery. May 10, 2021
We've found 298 results
NuVasive Benefits from International Recovery in 1Q21
The company grew in the mid-single-digits for the first quarter, as recovery in global markets offset some choppiness in the U.S. May 07, 2021
Zimmer Biomet Continues Technology Evolution in First Quarter
The company grew in the low single-digits for 1Q21, with important contributions from ROSA and its Signature ONE shoulder planner. May 06, 2021
SI-BONE Rides Record March Revenues for First Quarter Growth
The company realized around 40% of its first-quarter sales in March to overcome COVID and weather-related declines for 1Q21. May 05, 2021
Smith+Nephew Begins 2021 with Double-Digit Orthopedic Growth
The company’s orthopedic revenue grew 11% in 1Q21, driven by strength in its hip, sports medicine and robotics franchises. May 04, 2021
Orthofix Expects COVID Headwinds Through Second Quarter
The company grew less than 1% in 1Q21, driven by its M-6 disc and interbody portfolio. Orthofix sees COVID headwinds lasting through 1H21. May 03, 2021
Amplitude Surgical’s Foot and Ankle Sales Continue Growth Despite Pandemic
The company's foot and ankle business continued its steady growth in FY 3Q21, offsetting some impact from COVID's third wave in Europe. Apr 26, 2021
Calvin Lin Shares Insight on Prioritizing and Partnering
Mr. Lin has led the U.S. operations for United Orthopedic for more than a decade. He has learned that trust and people are the most critical factors in a successful business. Apr 22, 2021
4 Spine Acquisitions from 1Q21
The heavily player-populated spine market continues to be an active space for mergers and acquisitions, as companies of all sizes seek to build out their implant and technology portfolios. Four of the six publicly announced orthopedic OEM transactions we tracked in 1Q21 were spine-related. Apr 21, 2021
DePuy Synthes Exceeds Expectations in the First Quarter
The company grew 3.7% in 1Q21, driven by market recovery, improved organization execution and new product launches. Apr 21, 2021
